http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2817248-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e1507e3d41dd0993a8fecbd0340334b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6fe29b7e65fed6ec529c7ad0823de03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe04e00040a09940c0640bea209012c5 |
| publicationDate | 2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2817248-T3 |
| titleOfInvention | Pharmaceutical form for the prolonged release of active ingredients |
| abstract | Pharmaceutical form with at least one first active principle and at least one emulsifier, where the emulsifier is polyethylene glycol glycerides that are prepared by a reaction of monoglycerides, diglycerides and / or triglycerides with polyethylene glycol, where the polyethylene glycol chain is the hydrophilic part of the emulsifier and is connected with a lipophilic part, where the emulsifier has an HLB value of at least 1 and at most 16, where the mass ratio between active ingredient and emulsifier is from at least 1 to 30 and at most 1 a 1, and wherein the dosage form is a layered tablet comprising at least two layers, wherein the first layer is a first compartment and the second layer is a second compartment, wherein the first compartment comprises at least the first principle active ingredient and at least the emulsifier, and the emulsifier is not present in the second compartment, where the first active ingredient is cinnarizine or a cinnarizine salt to. |
| priorityDate | 2012-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 467.